ERICSSON INC. v. INTELLECTUAL VENTURES I LLC.
Contributed by Knobbe Martens. Originally published on Patexia; republished here as part of the LexDana archive.
Federal Circuit Summary
Before Prost, Newman, and Wallach. Appeal from the Patent Trial and Appeal Board.
Summary: An unsupported expert opinion does not constitute substantial evidence to contradict a prior art reference.
Ericsson petitioned for inter partes review of IV’s U.S. Pat. No. 6,952,408, directed to a method of frequency hopping. In its final written decision, the PTAB ruled that claim 1 is neither anticipated nor obvious, and did not separately analyze dependent claims 2-16.
The Federal Circuit reversed with regard to anticipation of claim 1 and vacated and remanded the decision as to the patentability of the remaining claims. The Court found unsupported expert testimony insufficient to contradict the anticipatory disclosure of a prior art reference, stating that “[t]o contradict a reference, an unsupported opinion is not substantial evidence.” Because it found each element of claim 1 was disclosed in the prior art reference, the Federal Circuit held that claim 1 was unpatentable as anticipated.
Judge Wallach dissented, stating that a court reviewing an agency’s adjudicative action should accept the agency’s factual findings if they are supported by substantial evidence. Judge Wallach stated that substantial evidence supports the PTAB’s determination that the challenged claims are not anticipated, and that the majority improperly substituted its own factual findings for those of the PTAB.
This case is: ERICSSON INC. v. INTELLECTUAL VENTURES I LLC.
Written by: Andrea Cheek and Mark Rubinshtein, Ph.D.
Edited by: Paul Stewart
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…